Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma [4]

British Journal of Surgery

Volumn 90, Issue 8, 2003, Pages 1022-

  Sen, G ^a   Rai, R ^a   Manas, D M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER STAGING; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; HUMAN; INOPERABLE CANCER; LETTER; LIVER CELL CARCINOMA; META ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; CHEMOEMBOLIZATION; LIVER TUMOR; METHODOLOGY; NOTE; SURVIVAL;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0042384788     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4361     Document Type: Letter

References (2)

1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
2. Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002; 68: 827-831.